COVID-19 vaccine effectiveness against severe COVID-19 requiring oxygen therapy, invasive mechanical ventilation, and death in Japan: A multicenter case-control study (MOTIVATE study).

MLA

Arashiro, Takeshi, et al. “COVID-19 Vaccine Effectiveness against Severe COVID-19 Requiring Oxygen Therapy, Invasive Mechanical Ventilation, and Death in Japan: A Multicenter Case-Control Study (MOTIVATE Study).” Vaccine, vol. 42, no. 3, Jan. 2024, pp. 677–88. EBSCOhost, https://doi.org/10.1016/j.vaccine.2023.12.033.

APA

Arashiro, T., Miwa, M., Nakagawa, H., Takamatsu, J., Oba, K., Fujimi, S., Kikuchi, H., Iwasawa, T., Kanbe, F., Oyama, K., Kanai, M., Ogata, Y., Asakura, T., Asami, T., Mizuno, K., Sugita, M., Jinta, T., Nishida, Y., Kato, H., … Suzuki, M. (2024). COVID-19 vaccine effectiveness against severe COVID-19 requiring oxygen therapy, invasive mechanical ventilation, and death in Japan: A multicenter case-control study (MOTIVATE study). Vaccine, 42(3), 677–688. https://doi.org/10.1016/j.vaccine.2023.12.033

Chicago

Arashiro, Takeshi, Maki Miwa, Hidenori Nakagawa, Junpei Takamatsu, Kunihiro Oba, Satoshi Fujimi, Hitoshi Kikuchi, et al. 2024. “COVID-19 Vaccine Effectiveness against Severe COVID-19 Requiring Oxygen Therapy, Invasive Mechanical Ventilation, and Death in Japan: A Multicenter Case-Control Study (MOTIVATE Study).” Vaccine 42 (3): 677–88. doi:10.1016/j.vaccine.2023.12.033.